Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5573)
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
300
Price
$1.34
Total Value
$402.00
Shares Held After
268,866
% of Holdings
0.1%
ABEONA THERAPEUTICS INC. (ABEO)
Alvino Mark — Director
Shares
13,500
Price
$5.23
Total Value
$70.57K
Shares Held After
48,752
% of Holdings
21.7%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
1,750
Price
$1.49
Total Value
$2.61K
Shares Held After
100,440
% of Holdings
1.7%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
409
Price
$1.53
Total Value
$625.77
Shares Held After
98,690
% of Holdings
0.4%
Exicure, Inc. (XCUR)
Exicure HiTron Inc. — 10% Owner
Shares
258,367
Price
$4.50
Total Value
$1.16M
Shares Held After
1,598,947
% of Holdings
13.9%
InspireMD, Inc. (NSPR)
Gleason Shane Thomas — Chief Commercial Officer
Shares
2,955
Price
$1.59
Total Value
$4.71K
Shares Held After
1,192,257
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
14
Price
$470.75
Total Value
$6.59K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
84
Price
$470.37
Total Value
$39.51K
Shares Held After
14
% of Holdings
85.7%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
451
Price
$469.18
Total Value
$211.60K
Shares Held After
98
% of Holdings
82.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,573
Price
$468.12
Total Value
$736.35K
Shares Held After
549
% of Holdings
74.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
321
Price
$467.09
Total Value
$149.94K
Shares Held After
2,122
% of Holdings
13.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
568
Price
$466.06
Total Value
$264.72K
Shares Held After
2,443
% of Holdings
18.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
966
Price
$465.11
Total Value
$449.30K
Shares Held After
3,011
% of Holdings
24.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,225
Price
$464.06
Total Value
$568.47K
Shares Held After
3,977
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,322
Price
$463.26
Total Value
$612.43K
Shares Held After
5,202
% of Holdings
20.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
271
Price
$461.12
Total Value
$124.96K
Shares Held After
6,524
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
268
Price
$459.86
Total Value
$123.24K
Shares Held After
6,795
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
377
Price
$458.74
Total Value
$172.94K
Shares Held After
7,063
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
372
Price
$457.92
Total Value
$170.35K
Shares Held After
7,440
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
63
Price
$456.87
Total Value
$28.78K
Shares Held After
7,812
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
26
Price
$470.75
Total Value
$12.24K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
156
Price
$470.37
Total Value
$73.38K
Shares Held After
26
% of Holdings
85.7%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
837
Price
$469.18
Total Value
$392.70K
Shares Held After
182
% of Holdings
82.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
2,922
Price
$468.12
Total Value
$1.37M
Shares Held After
1,019
% of Holdings
74.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
596
Price
$467.09
Total Value
$278.39K
Shares Held After
3,941
% of Holdings
13.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,055
Price
$466.06
Total Value
$491.70K
Shares Held After
4,537
% of Holdings
18.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,794
Price
$465.11
Total Value
$834.41K
Shares Held After
5,592
% of Holdings
24.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
2,274
Price
$464.06
Total Value
$1.06M
Shares Held After
7,386
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
2,456
Price
$463.26
Total Value
$1.14M
Shares Held After
9,660
% of Holdings
20.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
503
Price
$461.12
Total Value
$231.94K
Shares Held After
12,116
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
498
Price
$459.87
Total Value
$229.01K
Shares Held After
12,619
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
700
Price
$458.74
Total Value
$321.12K
Shares Held After
13,117
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
692
Price
$457.92
Total Value
$316.88K
Shares Held After
13,817
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
116
Price
$456.87
Total Value
$53.00K
Shares Held After
14,509
% of Holdings
0.8%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
3,750
Price
$39.35
Total Value
$147.56K
Shares Held After
36,010
% of Holdings
9.4%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
65,832
Price
$39.35
Total Value
$2.59M
Shares Held After
394,996
% of Holdings
14.3%
Pliant Therapeutics, Inc. (PLRX)
Cummings Keith Lamont — Chief Financial Officer
Shares
24,002
Price
$1.28
Total Value
$30.72K
Shares Held After
297,214
% of Holdings
7.5%
Pliant Therapeutics, Inc. (PLRX)
Cheung Lily — Chief Human Resource Officer
Shares
7,534
Price
$1.28
Total Value
$9.64K
Shares Held After
44,847
% of Holdings
14.4%
Pliant Therapeutics, Inc. (PLRX)
Coulie Bernard — Director
Shares
89,375
Price
$1.28
Total Value
$114.40K
Shares Held After
505,601
% of Holdings
15.0%
Pliant Therapeutics, Inc. (PLRX)
Kuo Minnie — Chief Operating Officer
Shares
6,917
Price
$1.28
Total Value
$8.85K
Shares Held After
37,806
% of Holdings
15.5%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
71,932
Price
$234.74
Total Value
$16.89M
Shares Held After
217,354
% of Holdings
24.9%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
23,948
Price
$234.74
Total Value
$5.62M
Shares Held After
99,776
% of Holdings
19.4%
Owlet, Inc. (OWLT)
Crawford Amanda — Chief Financial Officer
Shares
183
Price
$13.33
Total Value
$2.44K
Shares Held After
150,325
% of Holdings
0.1%
Owlet, Inc. (OWLT)
Harris Jonathan — President and CEO
Shares
2,311
Price
$13.33
Total Value
$30.81K
Shares Held After
264,396
% of Holdings
0.9%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
2,981
Price
$234.74
Total Value
$699.76K
Shares Held After
267,050
% of Holdings
1.1%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
19,234
Price
$234.74
Total Value
$4.51M
Shares Held After
226,615
% of Holdings
7.8%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
23,205
Price
$234.74
Total Value
$5.45M
Shares Held After
144,992
% of Holdings
13.8%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
17,806
Price
$234.74
Total Value
$4.18M
Shares Held After
177,591
% of Holdings
9.1%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$4.47
Total Value
$178.80K
Shares Held After
913,839
% of Holdings
4.2%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
3,867
Price
$35.67
Total Value
$137.94K
Shares Held After
21,354
% of Holdings
15.3%
Showing 3751–3800 of 5573 transactions (page 76 of 112)